Navigation path

Agriculture & food
Health & life sciences
  Allergy & asthma
  Communicable diseases
  Drugs & drug processes
  Genetic engineering
  Health & ageing
  Health & poverty
  Health & special needs
  Health systems & management
  Major diseases
  Medical research
  Molecular biology
  Public health
  Rare & orphan diseases
Human resources & mobility
Industrial research
Information society
International cooperation
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Social sciences and humanities
Special Collections
Video reports


   Health & life sciences

Last Update: 12-03-2013  
Related category(ies):
Human resources & mobility  |  Health & life sciences  |  Success stories


Countries involved in the project described in the article:
France  |  Germany  |  Spain  |  United Kingdom
Add to PDF "basket"

The visionary tools helping myopia researchers see further

Professor Frank Schaeffel has spent a quarter of a century studying myopia, the phenomenon of how the eye often grows too long and becomes short-sighted. Schaeffel, who is the Head of the Section of Neurobiology of the Eye at the Institute for Ophthalmic Research in Tübingen, Germany, has scored some crucial breakthroughs, yet for much of his career he has felt like a lone explorer in myopia research.

© Fotolia, 2013

While the other parts of the world have forged ahead in studying myopia, Europe has been vacant, he says. "Research on myopia exploded in the 1980s, with many new labs starting in the United States, Australia and Asia," he says. "However, we had just only one lab in Germany and one in the UK working on this topic."

In 2005, he decided to turn the situation around by putting together a European consortium to bundle myopia research. With the help of like-minded academics, he applied for a grant from the Marie Curie Research Training Network (RTN) and created MyEuropia. MyEuropia, which was granted €3.17 million from the European Commission, as a Marie Curie Action (MCA), provided a platform for students studying physics, genetics, computer science, engineering and other fields to receive training in biological techniques and other topics related to ophthalmology.

The network included Germany's University of Tübingen, the Rodenstock GmbH in Munich, Germany, King's College London, Cardiff University in Wales, University of Leipzig in Germany, Spain's University of Murcia, and the French biomedical and public health research institution INSERM. Their research addressed three areas in myopia:

  • Optics: designing and testing new spectacle types to reduce myopia progression, together with new optical techniques to obtain continuous scans of the refraction across the visual field;
  • Genetics: large-scale human screening studies to map the genome-carrying genes linked to myopia;
  • Biochemical signals: the growth signals released from the retina and how they reach the back of the eye.

Schaeffel says the research and the training of the students has been remarkably successful. It is not merely that seven doctoral students were trained and finished their degree, but that some 44 peer-reviewed original research articles were published in high-ranking journals, with more to come.

There were many scientific breakthroughs including the selectively breeding of chickens to become either very myopic or almost not myopic in just two generations, showing how short-sightedness is determined by many genes. MyEuropia's industrial partner, Munich-basedRodenstock, was able to develop new spectacle designs to cope with the optical problems of myopia, and to inhibit further myopia development. And the 13th International Myopia Conference was held in Tübingen in July 2010, an event that Schaeffel says meant that virtually every myopia researcher around the world now knows about the MyEuropia network.

Schaeffel says the project helped put the future of myopia research in the hands of young scientists at the start of their career. Around the world, the MyEuropia network was repeatedly quoted in myopia literature. Most of the students found post-doctorate positions, although the post-doctorate working at Rodenstock was hired by the European Patent office in Munich. One of the scientists received the respected Attempto Award, worth €7,500, based on his work in MyEuropia. "We have generated some long-ranging and also long-lasting scientific networks of the fellows, now working in different labs and different places but still friends," he says. "And we have developed new technologies that may in part become commercially available in the future."

Project details

  • Project acronym: MyEuropia
  • Participants: Germany(Coordinator),Spain,United Kingdom,France
  • FP6 Project N° 34021
  • EU contribution: € 3 174 000
  • Duration: October 2006 to September 2010

Convert article(s) to PDF

No article selected


Search articles

To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Project information on CORDIS

Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center